Stock listing

Frankfurt:B9A BioArctic AB Aktie

German listing (Frankfurt) of BioArctic AB · home listing Stockholm:BIOAB

Follow BioArctic AB into a list and get an email when it puts out news.

Share price · FWB:B9A

€26.26 EUR -0.74 (-2.7%)

Close on Nov 20, 2026

Past year +5.1% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€26.26 – €26.58 EURNov 20, 2026
Market cap
€2.33B EURAt the close on Nov 20, 2026 · price × 88.74M shares outstanding
52-week range
€25.00 – €35.26 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€3,033 EURMedian day 0 shares · 39 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
BioArctic AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
OTC:BRCTF$30.10 USD+0.105 (+0.4%)673$29.39$30.10$29.39$30.00Close on Nov 19, 2026
Frankfurt:B9A€26.26 EUR-0.74 (-2.7%)—€26.58€26.58€26.26€27.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:B9A · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€27.29-0.028-0.1%€27.33€27.53€27.290
€27.32-0.507-1.8%€27.61€27.81€27.30126
€27.82+0.866+3.2%€28.01€28.01€27.71126
€26.96+0.734+2.8%€26.96€26.96€26.96200
€26.22-2.21-7.8%€28.52€28.70€26.130
€28.43-0.143-0.5%€28.53€28.62€28.382
€28.58+0.787+2.8%€28.56€28.92€28.324
€27.79+0.466+1.7%€27.79€27.79€27.791,852
€27.32+0.365+1.4%€27.32€27.32€27.320
€26.96+0.478+1.8%€26.91€27.02€26.90734
€26.48-0.168-0.6%€26.48€26.48€26.48360
€26.65+0.137+0.5%€26.65€26.65€26.650
€26.51+0.07+0.3%€26.51€26.51€26.510
€26.44+0.988+3.9%€25.56€26.57€25.530
€25.45-0.652-2.5%€25.45€25.45€25.450
€26.11+0.77+3.0%€26.11€26.11€26.110
€25.34-0.0040.0%€25.34€25.34€25.340
€25.34-0.675-2.6%€25.34€25.34€25.340
€26.01+0.09+0.3%€26.31€26.31€25.870
€25.92-0.061-0.2%€25.92€25.92€25.920
€25.99+0.127+0.5%€25.96€26.14€25.868
€25.86-0.242-0.9%€25.87€25.87€25.86492
€26.10-0.259-1.0%€26.11€26.11€26.090
€26.36-0.20-0.8%€26.36€26.36€26.360
€26.56-0.261-1.0%€26.56€26.56€26.560
€26.82-0.038-0.1%€26.88€26.88€26.80430
€26.86+0.20+0.8%€26.89€26.89€26.780
€26.66-0.248-0.9%€26.66€26.66€26.660
€26.91-0.276-1.0%€26.91€26.91€26.910
€27.18-0.412-1.5%€27.23€27.23€26.880
€27.59-0.183-0.7%€28.00€28.09€27.2780
€27.78-1.315-4.5%€27.78€27.78€27.780
€29.09+0.364+1.3%€28.98€29.31€28.9120
€28.73+0.665+2.4%€28.14€28.75€28.120
€28.06-0.171-0.6%€28.06€28.06€28.060
€28.23+0.527+1.9%€28.23€28.23€28.23220
€27.71-0.207-0.7%€27.71€27.71€27.710
€27.91-0.435-1.5%€27.91€27.91€27.910
€28.35+0.38+1.4%€28.35€28.35€28.350
€27.97-0.846-2.9%€27.97€27.97€27.970
€28.82-0.419-1.4%€28.82€28.82€28.820
€29.23-0.185-0.6%€29.23€29.23€29.230
€29.42+0.62+2.2%€29.26€29.44€29.02200
€28.80-0.625-2.1%€28.80€28.80€28.800
€29.42-1.419-4.6%€29.42€29.42€29.420
€30.84+2.212+7.7%€30.84€30.84€30.8468
€28.63+0.211+0.7%€28.63€28.63€28.630
€28.42+0.022+0.1%€28.42€28.42€28.420
€28.40-0.92-3.1%€28.40€28.40€28.400
€29.32+0.046+0.2%€29.32€29.32€29.320
€29.27+0.467+1.6%€29.27€29.27€29.271,294
€28.81-2.494-8.0%€28.81€28.81€28.810
€31.30+1.431+4.8%€31.30€31.30€31.300
€29.87-0.629-2.1%€29.87€29.87€29.870
€30.50+0.70+2.3%€30.50€30.50€30.500
€29.80+0.153+0.5%€29.80€29.80€29.808
€29.64+0.855+3.0%€29.64€29.64€29.640
Ticker
Frankfurt:B9A
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All BioArctic AB news

BioArctic AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
10 in the last 12 months · 30 in all · newest Apr 21, 2026 · oldest 2025
Calls
14 calls with a replay · 14 with a transcript · latest Aug 26, 2026
Decks
27 decks · latest Aug 26, 2026

Where BioArctic AB is listed

ListingExchangeCountryCurrency
Stockholm:BIOAB · Home listingStockholmSwedenSEK
gettex:B9AgettexGermanyEUR
LSIN:0RV2LSINUnited KingdomSEK
Aquis:BIOABSAquisUnited KingdomSEK
OTC:BRCTFOTCUnited StatesUSD
LS Exchange:A2H5GSLS ExchangeGermanyEUR
Lang & Schwarz:A2H5GSLang & SchwarzGermanyEUR
Tradegate:B9ATradegateGermanyEUR
Frankfurt:B9A · This pageFrankfurtGermanyEUR
Hamburg:B9AHamburgGermanyEUR
Aquis:BIOABSAquisUnited KingdomSEK
Dusseldorf:B9ADusseldorfGermanyEUR
Munich:B9AMunichGermanyEUR
Stuttgart:B9AStuttgartGermanyEUR
Turquoise:BIOABSTurquoiseUnited KingdomSEK

Valuation

P/E 212× against a median of 3.4×: the highest of 2 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
20.45B SEK
P/E
212×
EV/sales
20.4×
EV/EBITDA
90.0×
Price/book
11.1×
Gross margin
93.2%
Operating margin
21.4%
Net margin
10.5%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
BioArctic AB Class B · OMXSTO:BIOA_BUS$2.19BUS$2.00B212×20.4×90.0×11.1×10.5%0.0×n/a
InSilico Medicine Cayman TopCo · HKEX:3696US$2.29BUS$1.71Bn/a30.3×n/a4.2×−626.5%0.0×n/a
Arcus Biosciences, Inc. · NYSE:RCUSUS$2.25BUS$1.72Bn/a17.2×n/a6.3×−453.0%0.3×1.37
SK bioscience Co.,Ltd. · KRX:302440US$2.24BUS$2.02Bn/a4.1×n/a1.7×−12.8%0.3×n/a
NewAmsterdam Pharma Company N.V. · NASDAQ:NAMSUS$2.20BUS$1.57Bn/a60.6×n/a3.5×−789.9%0.0×1.41
Lakefront Biotherapeutics · EURONEXT:LKFTUS$2.20B−US$260.8M3.4×−0.2×n/a0.6×60.2%0.0×n/a
Pharvaris N.V. · NASDAQ:PHVSUS$2.20BUS$1.89Bn/an/an/a7.5×n/a0.0×0.76
Beam Therapeutics Inc. · NASDAQ:BEAMUS$2.16BUS$1.22Bn/a8.3×n/a2.3×−73.9%0.1×1.90
Celldex Therapeutics, Inc. · NASDAQ:CLDXUS$2.15BUS$1.50Bn/an/an/a3.3×n/a0.0×1.07
Palvella Therapeutics, Inc. · NASDAQ:PVLAUS$2.09BUS$1.85Bn/an/an/a10.6×n/a0.0×1.50
Regencell Bioscience Holdings Limited · NASDAQ:RGCUS$2.07BUS$2.06Bn/an/an/a155×n/a0.0×1.57
Median of the othersUS$2.20BUS$1.71B3.4×12.8×3.8×−263.4%0.0×1.41

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
314.00 SEK · Analysts' mean
EPS, year to Dec 2026
5.75 · 2 analysts
Revenue, year to Dec 2026
1.52B · 3 analysts

Events

Next results
Nov 25, 2026 (expected)

Calls

CallWhenStatus
BioArctic (Stockholm:BIOA B) Q2 2026 Earnings CallWed, Aug 26, 2026 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q1 2026 Earnings CallWed, May 20, 2026 · 1:00 AM ETReplay
BioArctic (Stockholm:BIOA B) Q4 2025 Earnings CallWed, Feb 18, 2026 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q3 2025 Earnings CallThu, Nov 13, 2025 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q2 2025 Earnings CallThu, Aug 28, 2025 · 4:00 AM ETReplay
BioArctic (Stockholm:BIOA B) Q1 2025 Earnings CallWed, May 21, 2025 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q4 2024 Earnings CallThu, Feb 13, 2025 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q3 2024 Earnings CallThu, Nov 14, 2024 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q2 2024 Earnings CallThu, Aug 29, 2024 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q1 2024 Earnings CallFri, May 17, 2024 · 3:30 AM ETReplay
All 14 calls
CallWhenStatus
BioArctic (Stockholm:BIOA B) Q4 2023 Earnings CallWed, Feb 14, 2024 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q3 2023 Earnings CallWed, Nov 08, 2023 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q2 2023 Earnings CallWed, Jul 12, 2023 · 3:30 AM ETReplay
BioArctic (Stockholm:BIOA B) Q1 2023 Earnings CallThu, Apr 27, 2023 · 3:30 AM ETReplay

Results days

QuarterResultsShare move
Q2 2026Aug 26, 2026 · Before open−6.7%
Q1 2026May 20, 2026 · Before open+1.5%
Q4 2025Feb 18, 2026 · Before open+12.4%
Q3 2025Nov 13, 2025 · Before open+7.2%
Q2 2025Aug 28, 2025 · Before open+11.8%
Q1 2025May 21, 2025 · Before open+11.0%
Q4 2024Feb 13, 2025 · Before open+1.8%
Q3 2024Nov 14, 2024 · Before open+29.9%
Q2 2024Aug 29, 2024 · Before open+8.5%
Q1 2024May 17, 2024 · Before open−0.8%
All 20 quarters
QuarterResultsShare move
Q4 2023Feb 14, 2024 · Before open+8.2%
Q3 2023Nov 8, 2023 · Before open−1.8%
Q2 2023Jul 12, 2023 · Before open+0.5%
Q1 2023Apr 27, 2023 · After close+4.1%
Q4 2022Feb 3, 2023 · Before open−1.8%
Q3 2022Oct 20, 2022 · Before open+4.6%
Q2 2022Jul 12, 2022 · Before open−3.1%
Q1 2022Apr 28, 2022 · Before open−6.5%
Q4 2021Feb 3, 2022 · Before open−1.3%
Q3 2021Oct 21, 2021 · Before open−1.6%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings23 slidesAug 26, 2026
Q1 2026 Earnings PresentationEarnings26 slidesMay 20, 2026
Q4 2025 Earnings PresentationEarnings27 slidesFeb 18, 2026
Q3 2025 Earnings PresentationEarnings27 slidesNov 13, 2025
Q2 2025 Earnings PresentationEarnings29 slidesAug 28, 2025
Q1 2025 Earnings PresentationEarnings23 slidesMay 21, 2025
Q4 2024 Earnings PresentationEarnings19 slidesFeb 13, 2025
Q3 2024 Earnings PresentationEarnings23 slidesNov 14, 2024
Q2 2024 Earnings PresentationEarnings22 slidesAug 29, 2024
Q1 2024 Earnings PresentationEarnings22 slidesMay 17, 2024
All 27 decks
DeckKindSlidesDate
Q4 2023 Earnings PresentationEarnings19 slidesFeb 14, 2024
Q3 2023 Earnings PresentationEarnings20 slidesNov 8, 2023
Q2 2023 Earnings PresentationEarnings14 slidesJul 12, 2023
Q1 2023 Earnings PresentationEarnings22 slidesApr 27, 2023
Q4 2022 Earnings PresentationEarnings17 slidesFeb 3, 2023
Clinical Trials on Alzheimer's Disease (CTAD) 2022Conference74 slidesDec 2, 2022
Technical Presentation (August 2022)Technical9 slidesAug 4, 2022
Q2 2022 Earnings PresentationEarnings17 slidesJul 12, 2022
Q1 2022 Earnings PresentationEarnings18 slidesApr 28, 2022
FY2021 Earnings PresentationEarnings21 slidesFeb 3, 2022
Q2 2021 Earnings PresentationEarnings16 slidesJul 9, 2021
Q1 2021 Earnings PresentationEarnings16 slidesApr 21, 2021
FY2020 Earnings PresentationEarnings16 slidesFeb 4, 2021
Q3 2020 Earnings PresentationEarnings18 slidesOct 14, 2020
Q2 2020 Earnings PresentationEarnings18 slidesJul 10, 2020
Shareholder Meeting (2020)Shareholder meeting6 slides2020
Shareholder Meeting (May 2019)Shareholder meeting10 slidesMay 9, 2019

Open Decks

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue2.00B257.4M616.0M228.3M23.1M62.3M281.8M714.0M140.7M105.6M
Cost of revenue59.2M27.0M15.0M74.3M55.1M50.2M72.4M145.4M266.0K238.0K
Gross profit1.94B230.4M601.0M154.0M-31.9M12.1M209.4M568.6M140.4M105.4M
Research and development376.9M311.1M172.1M74.3M55.1M50.2M72.4M145.4M101.6M53.7M
Selling, general and administrative115.7M93.4M128.5M115.7M24.9M23.4M31.2M31.9M31.5M14.5M
Operating income1.26B-228.5M252.6M-10.2M-139.7M-82.3M112.5M488.8M19.3M74.6M
Depreciation and amortization12.8M10.7M18.4M14.6M13.1M10.9M9.20M2.06M1.99M1.56M
EBITDA1.27B-217.8M271.1M4.47M-126.6M-71.4M121.7M490.9M21.3M76.2M
Interest expense37.9M1.85M10.4M2.12M984.0K1.10M1.19M1.37M647.0K5.00K
Income before tax1.26B-189.5M276.5M-11.2M-140.5M-86.7M113.0M489.6M19.7M74.1M
Income tax233.3M-12.4M47.2M11.0K-20.7M-18.2M24.5M108.0M4.53M16.6M
Net income1.02B-177.1M229.2M-11.2M-119.8M-68.5M88.5M381.6M15.2M57.6M
Earnings per share, basic1,155,000.00-200,000.00260,000.00-0.13-1.36-0.781.004.330.170.65
Earnings per share, diluted1,152,000.00-200,000.00259,000.00-13.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.04B512.9M611.6M805.4M848.4M999.9M1.11B917.3M1.11B692.5M
Short-term investments1.15B266.0M500.0M
Receivables121.6M71.2M223.0K02.84M5.60M28.7M462.3M17.3M634.0K
Inventory-223.0K7.50M12.94M-462.3M2.81M-634.0K
Current assets2.49B1.01B1.15B820.8M861.8M1.01B1.14B1.38B1.13B699.5M
Property, plant and equipment36.9M39.5M23.5M23.5M17.0M39.9M37.1M9.29M7.09M5.64M
Total assets2.58B1.11B1.19B858.3M897.7M1.05B1.18B1.39B1.14B708.0M
Accounts payable23.9M50.5M29.9M21.5M11.8M14.3M8.22M14.8M7.59M11.7M
Current liabilities520.8M175.7M125.0M70.9M101.3M108.7M149.2M342.8M498.9M643.1M
Total debt44.1M54.2M4.98M10.0M15.9M20.8M27.4M
Total liabilities608.1M216.7M139.5M72.1M109.1M143.0M208.8M375.3M504.3M647.2M
Shareholders' equity1.97B894.9M1.05B786.2M788.7M907.3M974.5M1.02B636.1M60.8M
Shares outstanding88.7M88.5M88.5M88.1M88.1M88.1M88.1M88.1M88.1M88.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.43B-316.3M309.7M-31.6M-140.5M-92.3M327.2M-200.1M-135.3M675.1M
Capital spending-10.2M-26.6M-7.44M-12.7M-4.39M-12.5M-3.26M-4.25M-3.45M-2.97M
Free cash flow1.42B-343.0M302.3M-44.4M-144.8M-104.8M323.9M-204.3M-138.8M672.2M
Cash from investing-894.6M205.6M-507.5M-12.8M-4.41M-12.5M-3.27M-3.08M-2.81M-2.97M
Cash from financing26.9M5.69M14.1M-2.81M-7.39M-6.60M-138.5M-138.5M560.2M-105.1M
Dividends paid-26.0M-6.02M-15.0M-5.99M00-132.1M-132.1M-132.1M-105.1M
Share buybacks6.02M15.0M5.99M0560.2M
Change in cash563.3M-105.0B-183.7B-47.2B-152.3M-112.8M195.5M-193.1M417.8M578.7M

Open Financials

Cap table

Built by 6ix from BioArctic AB Class B’s releases

Common shares
74,344,689
Fully diluted
74,344,689

Fully diluted

LineShares
Common shares74,344,689

Share count over time

CountShares
Nov 22, 202674,344,689

Open Cap table

Shareholders

Funds

HolderSharesValueChangeAs of
Vanguard Total International Stock Index Fund611KUS$20.9M+11,658Jul 31, 2026
Vanguard Developed Markets Index Fund415KUS$14.1M+16,852Jun 30, 2026
iShares Core MSCI EAFE ETF336KUS$11.5M+17,740Jul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund164KUS$5.6M+10,274Jul 31, 2026
iShares MSCI EAFE Small-Cap ETF159KUS$5.44M−16,845Jul 31, 2026
Avantis International Small Cap Value ETF103KUS$3.91MNo changeMay 31, 2026
Vanguard European Stock Index Fund101KUS$3.44M+1,168Jul 31, 2026
Schwab International Small-Cap Equity ETF84,972US$3.24M−1,714May 31, 2026
iShares Core MSCI Total International Stock ETF84,748US$2.89M−3,442Jul 31, 2026
International Core Equity 2 Portfolio84,066US$2.87M+16,104Jul 31, 2026
All 47 holders
HolderSharesValueChangeAs of
iShares Core MSCI International Developed Markets ETF62,736US$2.14M+5,604Jul 31, 2026
Dimensional International High Profitability ETF40,248US$1.37M+4,161Jul 31, 2026
Vanguard Total World Stock Index Fund37,199US$1.27M+6,741Jul 31, 2026
College Retirement Equities Fund - Total Global Stock Account33,338US$1.13MNo changeJun 30, 2026
iShares International Small-Cap Equity Factor ETF30,250US$1.03M+16,379Jul 31, 2026
Dimensional International Core Equity 2 ETF29,738US$1.01M−262Jul 31, 2026
iShares Core MSCI Europe ETF28,335US$967K−600Jul 31, 2026
Goldman Sachs International Small Cap Insights Fund27,051US$924KNewJul 31, 2026
Fidelity Total International Index Fund26,197US$894K+1,992Jul 31, 2026
Dimensional International Core Equity Market ETF24,877US$847K+376Jul 31, 2026
Avantis International Large Cap Value ETF17,375US$662K+665May 31, 2026
International Sustainability Core 1 Portfolio16,943US$578K−2,983Jul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio12,556US$427KNo changeJun 30, 2026
Fidelity SAI International Small Cap Index Fund12,553US$428K−144Jul 31, 2026
Avantis International Equity ETF11,890US$453KNo changeMay 31, 2026
Large Cap International Portfolio11,600US$396K+6,529Jul 31, 2026
International Large Cap Growth Portfolio10,991US$375KNo changeJul 31, 2026
Vanguard ESG International Stock ETF8,830US$336KNo changeMay 31, 2026
Dimensional International Small Cap ETF8,212US$280K−488Jul 31, 2026
Dimensional International Sustainability Core 1 ETF7,511US$256KNo changeJul 31, 2026
Avantis International Small Cap Equity ETF6,721US$256K+920May 31, 2026
Thrivent International Equity Portfolio6,087US$207KNewJun 30, 2026
Avantis International Equity Fund5,177US$197KNo changeMay 31, 2026
iShares MSCI Europe Small-Cap ETF4,876US$166K−407Jul 31, 2026
Avantis Responsible International Equity ETF3,715US$142K+32May 31, 2026
Thrivent International Equity Fund3,571US$122K+1,617Jul 31, 2026
iShares MSCI World Small-Cap ETF3,041US$116K+166May 31, 2026
iShares Neuroscience and Healthcare ETF2,506US$85,563+480Jul 31, 2026
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund2,108US$71,813No changeJul 31, 2026
LVIP Dimensional International Core Equity Fund1,829US$62,137NewJun 30, 2026
State Street(R) SPDR(R) Portfolio Europe ETF1,798US$61,159−42Jun 30, 2026
Dimensional World ex. U.S. Core Equity 2 ETF1,748US$59,549No changeJul 31, 2026
Thrivent International Small Cap ETF840US$28,519First reportJun 30, 2026
M International Equity Fund603US$20,487First reportJun 30, 2026
Dimensional International Vector Equity ETF516US$17,579No changeJul 31, 2026
AZL DFA International Core Equity Fund415US$14,099No changeJun 30, 2026
First Trust IPOX Europe Equity Opportunities ETF198US$6,722+86Jun 30, 2026

Insider trades

InsiderTradeSharesPriceValueDate
Biljana Rizoska
Other member of the company's administrative, management or supervisory body
Sale3,000SEK 359.77SEK 1.08MFeb 18, 2026
Gunilla Osswald
Chief Executive Officer (CEO)/Managing Directory
Sale10,000SEK 359.77SEK 3.6MFeb 18, 2026
Ackelsta AB
Closely associated with Pär Gellerfors (Member of the Board of Directors)
Sale173,750SEK 310.00SEK 53.9MDec 18, 2025
Demban AB
Closely associated with Lars Lannfelt (Member of the Board of Directors)
Sale173,750SEK 310.00SEK 53.9MDec 18, 2025
Anna-Kaija Grönblad
Other member of the company's administrative, management or supervisory body
Buy500SEK 318.40SEK 159KDec 12, 2025
Anna-Kaija Grönblad
Other member of the company's administrative, management or supervisory body
Sale500SEK 316.40SEK 158KDec 11, 2025
Sten Mikael Moge
Other member of the company's administrative, management or supervisory body
Sale1,000SEK 319.60SEK 320KDec 4, 2025

Open Shareholders

Log in to ask 6ix AI your own questions about BioArctic AB.